AT1 RECEPTOR BLOCKADE AND AT2 RECEPTOR STIMULATION EFFECT ON THE RAS PEPTIDE LEVELS IN THE PREVENTION AND TREATMENT OF EXPERIMENTAL AUTOIMMUNE MYOCARDITIS (EAM) IN MALE LEW

MLA

Thomas Unger, et al. “At1 Receptor Blockade and At2 Receptor Stimulation Effect on the Ras Peptide Levels in the Prevention and Treatment of Experimental Autoimmune Myocarditis (Eam) in Male Lew.” Journal of Hypertension, vol. 36, June 2018, pp. e293–94. EBSCOhost, https://doi.org/10.1097/01.hjh.0000539859.58996.dd.

APA

Thomas Unger, U. Kintcher, Ludovit Paulis, R. Rajkovicova, P. Schmerler, Oliver Domenig, Marko Poglitsch, Simona Trubacova, M. Steckelings, & E. Kashina. (2018). At1 Receptor Blockade and At2 Receptor Stimulation Effect on the Ras Peptide Levels in the Prevention and Treatment of Experimental Autoimmune Myocarditis (Eam) in Male Lew. Journal of Hypertension, 36, e293–e294. https://doi.org/10.1097/01.hjh.0000539859.58996.dd

Chicago

Thomas Unger, U. Kintcher, Ludovit Paulis, R. Rajkovicova, P. Schmerler, Oliver Domenig, Marko Poglitsch, Simona Trubacova, M. Steckelings, and E. Kashina. 2018. “At1 Receptor Blockade and At2 Receptor Stimulation Effect on the Ras Peptide Levels in the Prevention and Treatment of Experimental Autoimmune Myocarditis (Eam) in Male Lew.” Journal of Hypertension 36 (June): e293–94. doi:10.1097/01.hjh.0000539859.58996.dd.